Dr. Anil Potti is a US based clinician. Board certified in Medical Oncology, he has been honored multiple times for his services and significant contributions in the field of cancer. He takes special initiative in providing care to patients with lung cancer and has won multiple accolades like the Alpha Omega Alpha, Outstanding Teacher of the Year award from medical students, Lisa Stafford Clinical Research Prize, Robert Silber Research Prize, Leonard B. Tow Humanism in Medicine Award and more. He received his Bachelor’s degree in Medicine and Surgery (M.B.B.S) in 1995 from the Christian Medical College & Hospital, Vellore, India. Dr. Anil Potti initially wanted to become a general medical physician but one of his personal experiences led him to the field of oncology.
Anil Potti received Residency Training at the University of North Dakota (UND) School of Medicine Fargo, North Dakota between 1996 and 1999, a Chief Residency in 2000, and completed a 3-year Fellowship Training program in hematology and oncology from the Duke University in 2006. Thereafter, Dr. Anil Potti holds the experience of working a faculty member in Multidisciplinary Thoracic Oncology Clinic at Duke University, Durham, NC.
Prior to receiving his Bachelor’s degree in the Medicine & Surgery, he studied Chemistry, Physics and Biology as majors at the LFJ College, Hyderabad, India. Dr. Potti has also made significant contributions in numerous research publications on cancer including Age- and-Sex specific genomic profiles in non-small cell lung cancer, and a genomic approach to colon cancer risk stratification yields biological insights into therapeutic opportunities.
Besides being a popular clinician, Anil Potti MD is also known for his humanitarian deeds. He strongly believes in working for the upliftment of the society and regularly donates his time and money to the local school system and the local church. He is actively associated with some of the premier organizations like Alpha Omega Alpha Honor Society, American Association of Cancer Research and American Society of Clinical Oncology.
|
